FDAnews
www.fdanews.com/articles/201262-axio-biosolutions-gains-ce-mark-for-wound-care-dressing
CE mark

Axio Biosolutions Gains CE Mark for Wound Care Dressing

February 8, 2021

Axio Biosolutions has earned CE mark certification for MaxioCel, an advanced wound care product.

The wound care dressing is designed to promote faster healing for chronic wounds, such as pressure ulcers, diabetic foot ulcers, venous leg ulcers, skin abrasions and postoperative surgical wounds, among others.

MaxioCel is an active dressing that manages exudates — fluids that leak out of blood vessels into nearby tissues — as well as providing pain relief and scar improvement for moderate-to-heavily exudating wounds.

View today's stories